8-KItem 5.02 · Officer/Director Change
Vertex Adds Former Boston Scientific CFO Daniel Brennan to Board
Filed with the SEC on · Summarized by InvestorsBot
Vertex Pharmaceuticals appointed Daniel Brennan to its board on October 20, 2026, increasing the board’s size from 10 to 11 members; he also joined the Audit and Finance Committee. Brennan, Boston Scientific’s former CFO, received a $400,000 restricted stock unit award that will vest in October 2027, and the filing reported no related-party transactions or appointment arrangements.